J&J: Study shows ‘real world evidence’ of COVID vaccine’s protection against breakthrough infection
January 06, 2022 at 17:02 PM EST
Last week, the company said its booster vaccine for COVID-19 was 85% effective against hospitalization in a study conducted in South Africa after the omicron variant became dominant.
